Volus Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 356.70%
(FY 2022)
- Profit 1975.09%
(FY 2022)
- Ebitda 869.23%
(FY 2022)
- Net Worth 2302.19%
(FY 2022)
- Total Assets 107.40%
(FY 2022)
About Volus Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Renu Sinha, Sunita, and Vandna Thakur serve as directors at the Company.
- CIN/LLPIN
U24100HR2017PTC067442
- Company No.
067442
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Volus Pharma Private Limited offer?
Volus Pharma Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Common Disease Medicines, Cough Syrup.
Who are the key members and board of directors at Volus Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Renu Sinha  | Director | 06-Feb-2017 | Current |
| Sunita | Director | 06-Feb-2017 | Current |
| Vandna Thakur | Director | 30-May-2021 | Current |
Financial Performance of Volus Pharma.
Volus Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 356.7% increase. The company also saw a substantial improvement in profitability, with a 1975.09% increase in profit. The company's net worth Soared by an impressive increase of 2302.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Volus Pharma?
Unlock access to Volus Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Volus Pharma?
Unlock and access historical data on people associated with Volus Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Volus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Volus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
